Maui Land & Pineapple Company, Inc. Reports Fiscal First Quarter 2025 Results and Announces New Scalable Agri-Business Venture
KAPALUA, Hawaii, May 15, 2025 (GLOBE NEWSWIRE) -- Maui Land & Pineapple Company, Inc. (NYSE: MLP) today reported financial results covering the quarter ended March 31, 2025. The Company also announced a new agriculture-based business venture designed to maximize the value of currently underutilized croplands and stimulate economic revitalization on Maui. Additional updates from the Company will be shared at its Annual Meeting of Stockholders, which will be held virtually on Wednesday, May 21, 2025, at 8:30 a.m., Hawai'i Standard Time, via conference call and posted to the Company website concurrently.
'In the first quarter of 2025, we advanced efforts to strengthen the fundamentals of our business segments and build the foundation for future growth by launching new initiatives to activate our landholdings,' said Race Randle, CEO of Maui Land & Pineapple Company, Inc. 'We delivered a 134% year-over-year gain in operating revenue, driven in part by significant increases in occupancy and income from commercial real estate leasing.'
'Despite higher operating expenses, we maintained strong liquidity and improved positive Adjusted EBIDTA, buoyed by greater operational efficiencies, higher operating revenue, and proceeds from the sales of non-strategic land parcels.'
'With the successful pension restructuring, the severance obligations to former leaders fully settled, and share-based compensation expenses expected to decrease, we are well-positioned to see improved GAAP income moving forward.'
MLP Announces New Agri-Business Venture
MLP is launching a new scalable business initiative to cultivate Agave, a drought tolerant, low maintenance crop which utilizes minimal water and is attracting a growing global demand for value-added products. This initiative will honor MLP's agricultural roots and aligns with our focus on accelerating the productivity of underutilized croplands, creating living wage jobs for local families, connecting people to the land, and boosting environmental and economic sustainability.
'We believe this new venture represents a significant opportunity to create long-term growth potential for the company which may be funded partially in partnership with mission-aligned partners. Our strategy complements our ongoing leasing and development projects while utilizing our prime landholdings to enable revenue upside potential from vertical integration with on-island distillation, regenerative agri-tourism, local distribution, and global expansion,' explained Randle.
A copy of the materials with additional details on the new initiative will be presented at our Annual Meeting of Stockholders and will be posted on the Company's website concurrently.
First Quarter 2025 Highlights
Operating Revenues – The Company's operating revenues totaled $5,804,000 for the three months ended March 31, 2025, as compared to $2,483,000 during the same period in 2024, an increase of $3,321,000, or 134%.
Land development and sales revenues amounted to $2,298,000 for the three months ended March 31, 2025, compared to no revenue during the same period in 2024. This is primarily attributed to $2,278,000 of contracting revenues from the Honokeana Homes Relief Housing Project with the State of Hawai'i. MLP is administering horizontal improvements for this project and has agreed to receive no direct profit from this effort.
Leasing revenues amounted to $3,219,000 for the three months ended March 31, 2025, as compared to $2,216,000 during the same period in 2024, an increase of $1,003,000, or 45%. This increase was the result of focused efforts to improve occupancy, bring leases to market rates, sign new leases for renovated commercial properties and land leases of dormant cropland for new agricultural use.
Costs and expenses – Operating costs and expenses totaled $7,583,000 for the three months ended March 31, 2025, as compared to $3,882,000 for the same period in 2024, an increase of $3,701,000.
The increase in operating costs were primarily attributed to a $2,278,000 increase in direct construction costs incurred on the Honokeana Homes Relief Housing Project as described above.
Other increases are attributable to $372,000 in leasing costs driven by rise of insurance premiums, property management fees and commissions on new leases, $460,000 in general and administrative expenses for additional employees hired during mid-2024, and $622,000 in non-cash share-based compensation primarily due to stock option vesting for six directors at March 31, 2025, as compared to similar costs from vesting for four directors during the same period in 2024. While the Company will continue to use equity as part of its compensation strategy, it does not anticipate using options, which the Company expects to result in a decrease in share-based compensation expenses in the future.
Other Income (non-operating) – Other income totaled $105,000 for the three months ended March 31, 2025, as compared to $104,000 for the same period in 2024, as bond interest and dividends remained consistent year over year.
Pension and post-retirement expense – Pension expenses totaled $6,919,000 for the three months ended March 31, 2025, as compared to $78,000 for the same period in 2024. Of this $6,841,000 increase, approximately $6,800,000 is a non-cash GAAP expense due to the qualified pension plan annuitization originated in the first quarter of 2025 and is expected to be fully terminated by September 30, 2025. This non-cash $6,800,000 GAAP expense will be offset by a corresponding non-cash gain to be reported as other comprehensive gain on the income statement. This is anticipated to occur and be reported in the second quarter of 2025.
Net loss – The net GAAP loss was ($8,640,000), or ($0.44) per basic and diluted common share for the three months ended March 31, 2025, compared to net loss of ($1,375,000) or ($0.07) per basic and diluted common share for the same period in 2024. The net loss in the first quarter of 2025 was primarily driven by the non-cash GAAP pension expenses, non-cash stock compensation expenses, increased general and administrative expenses, and $115,000 attributable to the former CEO's severance paid during the year. The former CEO's severance was paid over 24 months, has been fulfilled and will not be present after March 31, 2025.
Adjusted EBITDA (Non-GAAP) – For the three months ended March 31, 2025, after adjusting for non-cash income and expenses of $8,840,000, Adjusted EBITDA was $200,000. This represents a favorable increase of $412,000 as compared to the reported Adjusted EBITDA in the amount of ($212,000) for the three months ended March 31, 2024.
Cash and Investments Convertible to Cash (Non-GAAP) – Cash and Investments Convertible to Cash totaled $9,455,000 on March 31, 2025, a decrease of $67,000, as compared to $9,522,000 at March 31, 2024.
Non-GAAP Financial Measures
Certain non-GAAP financial measures are presented in this press release, including Adjusted EBITDA and Cash and Investments Convertible to Cash, to provide information that may assist investors in understanding the Company's financial results and financial condition and assessing its prospects for future performance. We believe that Adjusted EBITDA is an important indicator of our operating performance because it excludes items that are unrelated to, and may not be indicative of, our core operating results. We believe Cash and Investments Convertible to Cash are important indicators of liquidity because it includes items that are convertible into cash in the short term. These non-GAAP financial measures are not intended to represent and should not be considered more meaningful measures than, or alternatives to, measures of operating performance or liquidity as determined in accordance with GAAP. To the extent we utilize such non-GAAP financial measures in the future, we expect to calculate them using a consistent method from period to period.
EBITDA is a non-GAAP financial measure defined as net income (loss) excluding interest, taxes, depreciation and amortization. Adjusted EBITDA is further adjusted for non-cash stock-based compensation expense, pension and post-retirement expenses, and other non-recurring (gains)/losses, which include (gains)/losses from asset impairments, asset dispositions, and derecognition of other assets. Adjusted EBITDA is a key measure used by the Company to evaluate operating performance, generate future operating plans and make strategic decisions for the allocation of capital. The Company presents Adjusted EBITDA to provide information that may assist investors in understanding its financial results. However, Adjusted EBITDA is not intended to be a substitute for net income (loss). A reconciliation of Adjusted EBITDA to the most directly comparable GAAP financial measure is provided further below.
Cash and Investments Convertible to Cash is a non-GAAP financial measure defined as cash and cash equivalents plus restricted cash and investments. Cash and Cash Investments Convertible to Cash is a key measure used by the Company to evaluate internal liquidity.
Additional Information
More information about Maui Land & Pineapple Company's first quarter 2025 operating results are available in the Form 10-Q filed with the Securities and Exchange Commission and posted at mauiland.com.
About Maui Land & Pineapple Company
Maui Land & Pineapple Company, Inc. (NYSE: MLP) is dedicated to the thoughtful stewardship of its portfolio, including over 22,000 acres of land along with approximately 247,000 square feet of commercial real estate. The Company envisions a future where Maui residents thrive in more resilient communities with sufficient housing supply, economic stability, food and water security, and deep connections between people and place. For over a century, MLP has built a legacy of thoughtful stewardship through conservation, agriculture, community building, and land management. The Company continues this legacy today with a mission to thoughtfully maximize the productive use of its assets to meet the critical needs of current and future generations.
Company assets include land for future residential communities and mixed-use projects within the world-renowned Kapalua Resort, home to luxury hotels such as The Ritz-Carlton Maui and Montage Kapalua Bay, two championship golf courses, pristine beaches, a network of walking and hiking trails, and the Pu'u Kukui Watershed, the largest private nature preserve in Hawai'i.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements regarding the Company's ability to put its land into productive use, our ability to cultivate and commercialize Agave, and our ability to reduce share-based compensation expenses. These forward-looking statements are based upon the current beliefs and expectations of management and are inherently subject to significant business, economic and competitive uncertainties, and contingencies, many of which are beyond the control of the Company. In addition, these forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Actual results may differ materially from the anticipated results discussed in these forward-looking statements because of possible uncertainties. Factors that could cause actual results to differ materially from those expressed in the forward-looking statements are discussed in the Company's reports (such as Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K) filed with the SEC and available on the SEC's Internet site (http://www.sec.gov). We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether because of new information, future developments or otherwise.
# # #
CONTACT
Investors:
Wade Kodama | Chief Financial Officer | Maui Land & Pineapple Company
e: wade@mauiland.com
Media:
Ashley Takitani Leahey | Vice President | Maui Land & Pineapple Companye: ashley@mauiland.comDylan Beesley | Senior Vice President | Bennet Group Strategic Communicationse: dylan@bennetgroup.com
MAUI LAND & PINEAPPLE COMPANY, INC. AND SUBSIDIARIESCONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)(Unaudited)
Three Months Ended March 31,
2025
2024
(in thousands except per share amounts)
OPERATING REVENUES
Land development and sales
$
2,298
$
-
Leasing
3,219
2,216
Resort amenities and other
287
267
Total operating revenues
5,804
2,483
OPERATING COSTS AND EXPENSES
Land development and sales
2,323
266
Leasing
1,364
992
Resort amenities and other
612
436
General and administrative
1,517
1,057
Share-based compensation
1,581
959
Depreciation
186
172
Total operating costs and expenses
7,583
3,882
OPERATING LOSS
(1,779
)
(1,399
)
Gain on assets disposal
1
-
Other income
105
104
Pension and other post-retirement expenses
(6,919
)
(78
)
Interest expense
(48
)
(2
)
NET LOSS
$
(8,640
)
$
(1,375
)
Other comprehensive income - pension, net
79
68
TOTAL COMPREHENSIVE LOSS
$
(8,561
)
$
(1,307
)
NET LOSS PER COMMON SHARE-BASIC AND DILUTED
$
(0.44
)
$
(0.07
)
MAUI LAND & PINEAPPLE COMPANY, INC. AND SUBSIDIARIESCONSOLIDATED BALANCE SHEETS
March 31, 2025
December 31, 2024
(unaudited)
(audited)
(in thousands except share data)
ASSETS
CURRENT ASSETS
Cash and cash equivalents
$
7,882
$
6,835
Accounts receivable, net
2,650
5,016
Investments
1,573
2,687
Prepaid expenses and other assets
375
507
Assets held for sale
82
82
Total current assets
12,562
15,127
PROPERTY & EQUIPMENT, NET
17,350
17,401
OTHER ASSETS
Investment in joint venture
42
968
Deferred development costs
14,854
14,410
Other noncurrent assets
2,424
2,233
Total other assets
17,320
17,611
TOTAL ASSETS
$
47,232
$
50,139
LIABILITIES & STOCKHOLDERS' EQUITY
LIABILITIES
CURRENT LIABILITIES
Accounts payable
$
2,460
$
2,321
Payroll and employee benefits
233
908
Accrued retirement benefits, current portion
7,370
140
Deferred revenue, current portion
1,148
833
Long-term debt, current portion
85
85
Line of credit
3,000
3,000
Other current liabilities
556
730
Contract overbillings
901
3,180
Total current liabilities
15,753
11,197
LONG-TERM LIABILITIES
Accrued retirement benefits, noncurrent portion
1,447
2,368
Deferred revenue, noncurrent portion
1,200
1,233
Deposits
1,938
1,968
Long-term debt, noncurrent portion
156
168
Other noncurrent liabilities
22
24
Total long-term liabilities
4,763
5,761
TOTAL LIABILITIES
20,516
16,958
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY
Preferred stock--$0.0001 par value; 5,000,000 shares authorized; no shares issued and outstanding
-
-
Common stock--$0.0001 par value; 43,000,000 shares authorized; 19,718,150 and 19,663,780 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively
86,799
85,877
Additional paid-in-capital
16,376
15,202
Accumulated deficit
(69,648
)
(61,008
)
Accumulated other comprehensive loss
(6,811
)
(6,890
)
Total stockholders' equity
26,716
33,181
TOTAL LIABILITIES & STOCKHOLDERS' EQUITY
$
47,232
$
50,139
MAUI LAND & PINEAPPLE COMPANY, INC. AND SUBSIDIARIES
SUPPLEMENTAL FINANCIAL INFORMATION
(NON-GAAP) UNAUDITED
Three Months Ended
March 31,
2025
2024
(In thousands except per share
amounts)
NET LOSS
$
(8,640
)
$
(1,375
)
Non-cash income and expenses
Interest expense
2
6
Depreciation
186
172
Amortization of licensing fee revenue
(33
)
(33
)
Share-based compensation
Vesting of Stock Options granted to Board Chair and Directors
975
439
Vesting of Stock Compensation granted to Board Chair and Directors
174
137
Vesting of Stock Options granted to CEO
199
197
Vesting of employee Incentive Stock
231
185
Bad debt expense
209
5
Pension and other post-retirement expenses
6,897
55
ADJUSTED EBITDA (LOSS)
$
200
$
(212
)
Three Months Ended
Year Ended
March 31, 2025
December 31, 2024
(in thousands)
CASH AND INVESTMENTS
Cash and cash equivalents
$
7,882
$
6,835
Investments, current portion
1,573
2,687
TOTAL CASH AND INVESTMENTS CONVERTIBLE TO CASH
$
9,455
$
9,522
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
29 minutes ago
- Yahoo
Global Uranium Corp. Announces LIFE Offering for up to C$1,500,000
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, June 10, 2025 (GLOBE NEWSWIRE) -- Global Uranium Corp. (CSE: GURN | FRA: Q3J) (the 'Company') is pleased to announce that it intends to complete a non-brokered private placement financing (the 'Offering') of a minimum of 1,666,666 units of the Company (each, a 'Unit') and a maximum of 10,000,000 Units, at a price of C$0.15 per Unit, for gross minimum proceeds of C$250,000 and gross maximum proceeds of C$1,500,000. Each Unit shall be comprised of one common share in the capital of the Company (each, a 'Share') and one Share purchase warrant ('Warrant'), with each Warrant entitling the holder to purchase one Share at a price of C$0.20 for a period of 24 months from Closing (as defined herein). Closing of the Offering is anticipated to occur on or about July 25, 2025 ('Closing'), subject to the satisfaction of certain conditions, including, but not limited to, the receipt of all necessary regulatory and other approvals. The net proceeds of the Offering are intended to be used for exploration activities, for general administrative expenditures, and for general working capital purposes. Subject to compliance with applicable regulatory requirements and in accordance with National Instrument 45-106 – Prospectus Exemptions ('NI 45-106'), the securities issuable under the Offering will be offered for sale to purchasers resident in all of the provinces of Canada (except Quebec) pursuant to the listed issuer financing exemption under Part 5A.2 of NI 45-106 (the 'LIFE Exemption'). As such, the securities issued to subscribers will not be subject to resale restrictions in accordance with applicable Canadian securities laws. There is an offering document dated June 10, 2025 related to the Offering that can be accessed under the Company's profile at and on the Company's website at This offering document contains additional detail regarding the Offering, including additional detail regarding the expected use of proceeds therefrom. Prospective investors in the Offering should read this offering document before making an investment decision. The securities described herein have not been and will not be registered under the United States Securities Act of 1933, as amended (the 'U.S. Securities Act'), or any United States state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, United States persons absent registration or any available exemption from the registration requirements of the U.S. Securities Act and applicable United States state securities laws. This press release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. ABOUT GLOBAL URANIUM CORP. Global Uranium Corp. focuses on exploring and developing uranium assets primarily in North America. The Company currently holds key uranium projects: the Wing Lake Property in the Mudjatik Domain of Northern Saskatchewan, Canada; the Northwest Athabasca Joint Venture with Forum Energy Metals Corp. and NexGen Energy Ltd. in the Northwest Athabasca region of Saskatchewan, Canada; the Astro Uranium Project with Cosa Resources Corp in the eastern Athabasca Basin, Saskatchewan; and the Great Divide Basin District Projects, the Gas Hills District Projects, and the Copper Mountain District Projects in Wyoming, USA. ON BEHALF OF THE BOARD OF DIRECTORSUngad ChaddaCEO 587-330-0045info@ FORWARD-LOOKING STATEMENTS Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words 'could', 'intend', 'expect', 'believe', 'will', 'projected', 'estimated' and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events. In particular, this press release contains forward-looking information relating to, among other things, the Offering, including the total anticipated proceeds, the expected use of proceeds, and the closing (including the proposed closing date) of the Offering. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information, including the assumption that the Company will close the Offering on the timeline anticipated, will raise the anticipated amount of gross proceeds from the Offering and will use the proceeds of the Offering as anticipated. Those assumptions and factors are based on information currently available to the Company. Although such statements are based on reasonable assumptions of the Company's management, there can be no assurance that any conclusions or forecasts will prove to be accurate. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information. Such factors include: the risk that the Offering does not close on the timeline expected, or at all; the risk that the Company raises less than the anticipated amount of gross proceeds from the Offering; the risk that the Company does not use the proceeds from the Offering as currently expected; risks inherent in the exploration and development of mineral deposits, including risks relating to receiving requisite permits and approvals, changes in project parameters or delays as plans continue to be redefined, that mineral exploration is inherently uncertain and that the results of mineral exploration may not be indicative of the actual geology or mineralization of a project; that mineral exploration may be unsuccessful or fail to achieve the results anticipated by the Company; operational risks; regulatory risks, including risks relating to the acquisition of the necessary licenses and permits; financing, capitalization and liquidity risks; title and environmental risks; and risks relating to the failure to receive all requisite regulatory approvals. The forward-looking information contained in this release is made as of the date hereof, and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein. The Canadian Securities Exchange has not reviewed, approved, or disapproved the contents of this press release.Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
39 minutes ago
- Yahoo
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FOSTER CITY, Calif., June 11, 2025--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that on June 10, 2025, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 115,620 shares of common stock and 57,740 restricted stock units ("RSUs") to 10 new employees under Mirum's 2020 Inducement Plan. The Compensation Committee of Mirum's Board of Directors approved the awards as an inducement material to the new employees' employment in accordance with Nasdaq Listing Rule 5635(c)(4). Each stock option has an exercise price per share equal to $48.98 per share, Mirum's closing trading price on June 10, 2025, and will vest over four years, with 25% of the underlying shares vesting on the one-year anniversary of the applicable vesting commencement date and the balance of the underlying shares vesting monthly thereafter over 36 months, subject to the new employees' continued service relationship with Mirum through the applicable vesting dates. The RSUs will vest over three years, with 33% of the underlying shares vesting on each anniversary of the applicable vesting commencement date, subject to the new employees' continued service relationship with Mirum through the applicable vesting dates. The awards are subject to the terms and conditions of Mirum's 2020 Inducement Plan and the terms and conditions of an applicable award agreement covering the grant. About Mirum Pharmaceuticals, Inc. Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases affecting children and adults. Mirum has three approved medications: LIVMARLI® (maralixibat), CHOLBAM® (cholic acid) capsules, and CTEXLI™ (chenodiol) tablets. LIVMARLI, an IBAT inhibitor, is approved for the treatment of two rare liver diseases affecting children and adults. It is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome in the U.S. (three months and older), in Europe (two months and older), and in other regions globally. It is also approved in the U.S. in cholestatic pruritus in PFIC patients 12 months of age and older; in Europe, it is approved for patients with PFIC three months of age and older. Mirum is also initiating the Phase 3 EXPAND study, a label expansion opportunity for LIVMARLI in additional settings of cholestatic pruritus. CHOLBAM is FDA-approved for the treatment of bile acid synthesis disorders due to single enzyme deficiencies and adjunctive treatment of peroxisomal disorders in patients who show signs or symptoms of liver disease. CTEXLI is FDA-approved for the treatment of cerebrotendinous xanthomatosis (CTX) in adults. Mirum's late-stage pipeline includes two investigational treatments for several rare diseases. Volixibat, an IBAT inhibitor, is being evaluated in two potentially registrational studies including the Phase 2 VISTAS study for primary sclerosing cholangitis (PSC) and Phase 2b VANTAGE study for primary biliary cholangitis (PBC). Volixibat has been granted Breakthrough Therapy Designation for the treatment of cholestatic pruritus in patients with PBC. Mirum is also planning for a Phase 2 study evaluating MRM-3379, a PDE4D inhibitor for the treatment of Fragile X syndrome, a rare genetic neurocognitive disorder. To learn more about Mirum, visit and follow Mirum on Facebook, LinkedIn, Instagram and X. View source version on Contacts Investor Contact: Andrew McKibbenir@ Media Contact: Erin Murphymedia@
Yahoo
an hour ago
- Yahoo
Studio 17 Spotlights Kern County SHRM Annual Conference
Presented by: Kern County SHRM On today's Studio 17, Kait Hill spoke with with Jackie Andrade, Conference Director, and Sky Newton, Conference Vice Chair, from Kern County SHRM to discuss their upcoming annual conference. Kern County SHRM plays a key role in connecting the local business community through leadership, professional development, and networking. With a long-standing presence in the region, Kern County SHRM's conference promises powerful keynote speakers and fresh topics that reflect the evolving workplace. The event welcomes not only HR professionals but anyone interested in career growth and leadership skills. Attendees can look forward to dynamic sessions and a vibrant atmosphere that encourages learning and connection. For those wanting to get involved year-round or register for the conference, more information is available on the . Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.